Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1374-1381

  Ollivier, V ^a   Chabbat, J ^b   Herbert, J M ^c   Hakim, J ^a   De Prost, D ^a,d  

^a INSERM   (France)

^b Lab Francais Fractionnement B   (France)

^c SANOFI   (France)

^d HÔPITAL LOUIS MOURIER   (France)

Author keywords

Activated factor VII; Fibroblasts; Proteases; Tissue factor; Vascular endothelial growth factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 7A; CALCIUM IONOPHORE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CALCIUM CELL LEVEL; CELL COMMUNICATION; ENZYME ACTIVATION; ENZYME INDUCTION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR AFFINITY;

EID: 0034101945     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1374     Document Type: Article

References (39)

1. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 1988;23:339-368.
2. Fischer EG, Ruf W, Mueller BM. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res. 1995;55:1629-1632.
3. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994;94: 1320-1327.
4. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Vanvlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature. 1996;383:73-75.
5. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 1995;270:4650-4660.
6. Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NCH, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem. 1998;273: 6228-6232.
7. Masuda M, Nakamura S, Murakami T, Komiyama Y, Takahashi H. Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in cultured human monocytes. Eur J Immunol. 1996;26: 2529-2532.
8. Pendurthi UR, Alok D, Rao LVM. Binding of factor Vila to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc Natl Acad Sci U S A. 1997; 94:12598-12603.
9. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241-1253.
10. Taniguchi T, Kakkar AK, Tuddenham EGD, Williamson RCN, Lemoine NR. Enhanced expression of urokinase receptor induced through the tissue factor-factor Vila pathway in human pancreatic cancer. Cancer Res. 1998;58:4461-4467.
11. Ollivier V, Bentolila S, Chabbat J, Hakim J, de Prost D. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998;91:2698-2703.
12. Thim L, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor Vila from plasma and transfected baby hamster kidney cells. Biochemistry. 1988;27:7785-7793.
13. Sørensen BB, Persson E, Freskgård PO, Kjalke M, Ezban M, Williams T, Rao LVM Incorporation of an active site inhibitor in factor Vila alters the affinity for tissue factor. J Biol Chem. 1997;272:11863-11868.
14. Stanssens P, Bergum PW, Gansemans Y, Jespers L, Laroche Y, Huang S, Maki S Messens J, Lauwereys M, Cappello M, Hotez PJ, Lasters I, Vlasuk GP Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci U S A. 1996;93:2149-2154.
15. Ruf W, Edgington TS. An anti-tissue factor monoclonal antibody which inhibits TF-VIIa complex is a potent anticoagulant in plasma. Thromb Haemost. 1991;66:529-533.
16. Altieri DC, Edgington TS. Identification of effector cell protease receptor-1: a leukocyte-distributed receptor for the serine protease factor Xa. J Immunol. 1990;145:246-253.
17. Burnouf T, Michalski C, Goudemand M, Huart JJ. Properties of highly purified human factor IX: C therapeutic concentrate prepared by conventional chromatography. Vox Sang. 1989;57:225-232.
18. Grynkiewicz G, Poenie M, Tsien RJ. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
19. El Benna JE, Dang PM, Gaudry M, Fay M, Morel F, Hakim J, Gougerot-Pocidalo MA. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation: regulation by protein kinase C-dependent and independent pathways. J Biol Chem. 1997;272:17204-17208.
20. Treio J, Connolly AJ, Coughlin SR. The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts: loss of responses in fibroblasts from receptor knockout mice. J Biol Chem. 1996;271:21536-21541.
21. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothehal growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A. 1997;94:663-668.
22. Senden NHM, Jeunhomme TMAA, Heemskerk JWM, Wagenvoord R, Vantveer C, Hemker HC, Buurman WA. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol. 1998;161:4318-4324.
23. Herault JP, Bono F, Avril C, Schaeffer P, Herbert JM. Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors. Biochem Pharmacol. 1999;57:603-610.
24. Nicholson AC, Nachman RL, Altieri DC, Summers BD, Ruf W, Edgington TS, Hajjar DP. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem. 1996;271:28407-28413.
25. Herbert JM, Bono F, Herault JP, Avril C, Dol F, Mares AM, Schaeffer P. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest. 1998;101:993-1000.
26. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
27. Milanini J, Vinals F, Pouyssegur J, Pages G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem. 1998:273: 18165-18172.
28. Sorensen BB, Freskgard PO, Nielsen LS, Rao LVM, Ezban M, Petersen LC. Factor VIIa-induced signal transduction via the p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa, and is independent of the tissue factor cytoplasmic domain. J Biol Chem. 1999;274:21349-21354.
29. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996;32A. 2413-2422.
30. Fukumura D, Xavier R, Sugiura T, Chen Y, Park E-C, Lu N, Selig M Nielsen G, Taksir T, Jain RK, Seed B. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715-725.
31. Mueller BM, Ruf W. Requirement for binding of catalytically active factor Vila in tissue factor-dependent experimental metastasis. J Clin Invest. 1998;101:1372-1378.
32. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA. 1995;92:8205-8209.
33. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A. 1999;96:8663-8668.
34. Ruf W, Mueller BM. Tissue factor signaling. Thromb Haemost. 1999;82: 175-182.
35. Inoue M, Hiroshi I, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun T-H, Masatsugu K, Becker AE, Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Circulation. 1998;98:2108-2116.
36. Zalewski SY. Vascular myofibroblasts: lessons from coronary repair and remodeling. Arterioscler Thromb Vase Biol. 1997;17:417-422.
37. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998; 98:2800-2804.
38. Vanbelle E, Maillard L, Tio FO, Isner JM. Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimai formation. Biochem Biophys Res Commun. 1997;235:311-316.
39. Tsurumi Y, Kearney M, Chen DF, Silver M, Takeshita S, Yang JH, Symes JF, Isner JM. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation. 1997; 96:382-388.